| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/05/2001 | EP1158990A1 Administration of an anti-endotoxin drug by intravenous infusion |
| 12/05/2001 | EP1158989A2 Use of inhibitors of endotoxin for the treatment of chachexia |
| 12/05/2001 | EP1158988A2 Corticosteroid formulation |
| 12/05/2001 | EP1158987A1 Methods of increasing bone volume using non-naturally-occurring fp selective agonists and antiresorptive compounds |
| 12/05/2001 | EP1158986A1 Protease inhibitors |
| 12/05/2001 | EP1158985A1 OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS |
| 12/05/2001 | EP1158984A1 Inhibitors of prenyl-protein transferase |
| 12/05/2001 | EP1158983A1 Inhibitors of prenyl-protein transferase |
| 12/05/2001 | EP1158982A2 Inhibitors of prenyl-protein transferase |
| 12/05/2001 | EP1158981A1 Use of remifentanyl for reducing blood pressure |
| 12/05/2001 | EP1158979A2 Compositions of remifentanil |
| 12/05/2001 | EP1158978A1 Medicament against dysmenorrhoea and premenstrual syndrome |
| 12/05/2001 | EP1158977A2 Method and composition for administering a cyclooxygenase-2 inhibitor |
| 12/05/2001 | EP1158976A2 VACUOLAR-TYPE (H+)-ATPase-INHIBITING COMPOUNDS, COMPOSITIONS, AND USES THEREOF |
| 12/05/2001 | EP1158975A1 Use of isoflavones and/or african plum extracts for preparing a composition designed to inhibit 5$g(a)-reductase activity, in pharmacology particularly in dermatology, in cosmetics and as food additive |
| 12/05/2001 | EP1158973A2 Use of sulfamate derivatives for treating impulse control disorders |
| 12/05/2001 | EP1158972A1 Treatment of hypertension with compounds that inhibit the destruction of enkephalins or endorphins |
| 12/05/2001 | EP1158971A1 Gardos channel antagonists |
| 12/05/2001 | EP1158970A1 Combinations of formoterol and a tiotropium salt |
| 12/05/2001 | EP1158969A2 Use of a non-naturally-occurring ep1 selective agonist for increasing bone volume |
| 12/05/2001 | EP1158968A2 Jak-3 inhibitors for treating allergic disorders |
| 12/05/2001 | EP1158967A1 Transdermal device comprising non-steroidal anti-inflammatory drugs incorporated in acrylic adhesive polymer matrix |
| 12/05/2001 | EP1158965A2 Capsule system |
| 12/05/2001 | EP1158963A1 Controlled-release compositions of betahistine |
| 12/05/2001 | EP1158962A1 Method for producing solid dosage forms containing cyclodextrin |
| 12/05/2001 | EP1158959A1 Compositions and methods for improved delivery of hydrophobic therapeutic agents |
| 12/05/2001 | EP1158958A1 Improved powdery pharmaceutical compositions for inhalation |
| 12/05/2001 | EP1158957A1 Liquid suppository composition of diclofenac sodium |
| 12/05/2001 | EP1158953A1 Aerosol hair spray compositions comprising combinations of silicone-grafted copolymers |
| 12/05/2001 | EP1158950A1 Anticonvulsant derivatives useful in treating essential tremor |
| 12/05/2001 | EP1158925A2 Methods for treating superficial bladder carcinoma |
| 12/05/2001 | EP1158872A1 Dietary compositions and methods |
| 12/05/2001 | EP1146035A9 Crystal polymorphism of aminoethylphenoxyacetic acid derivative |
| 12/05/2001 | EP1142903A9 BRAIN CELL OR NERVE CELL-PROTECTIVE AGENTS COMPRISING GINSENOSIDE Rb 1? |
| 12/05/2001 | EP1067904B1 Solid, quick dissolving cetirizine formulations |
| 12/05/2001 | EP1063983B1 Transdermal therapeutic system (tts) containing oxybutynin |
| 12/05/2001 | EP1026947B1 Composition and method for treating penile erectile dysfunction |
| 12/05/2001 | EP1019039B1 Compressed nitroglycerin tablet and its method of manufacture |
| 12/05/2001 | EP1017377B1 Use of 6, 7-substituted 2-aminotetralines for the treatment of cytokine mediated inflammatory conditions |
| 12/05/2001 | EP1001993B1 Method for the continuous production of hydrolytically broken down and possibly substituted starch, use of hydrolytically broken down starch and device for producing same |
| 12/05/2001 | EP0996424B1 Solid pharmaceutical preparation |
| 12/05/2001 | EP0994872B9 4-phenylpiperidine compounds |
| 12/05/2001 | EP0994693B1 Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin |
| 12/05/2001 | EP0971880B1 Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid |
| 12/05/2001 | EP0970195A4 Fatty-acid amide hydrolase |
| 12/05/2001 | EP0941094B1 Process for manufacturing ophthalmic suspensions containing brinzolamide |
| 12/05/2001 | EP0937036B1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors |
| 12/05/2001 | EP0928183B1 Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis |
| 12/05/2001 | EP0911327B1 Novel pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising the same as the active ingredient |
| 12/05/2001 | EP0904282B1 Novel cationic cholesteryl derivatives containing cyclic polar groups |
| 12/05/2001 | EP0868187B1 Transdermal estradiol/progestogen agent patch and its production |
| 12/05/2001 | EP0863760B1 Use of antimineralocorticoid compounds against drug withdrawal syndrome |
| 12/05/2001 | EP0862414B1 Ophthalmic compositions containing cyclodextrins and quaternary ammonium compounds |
| 12/05/2001 | EP0859596B1 Gel formulations containing growth factors |
| 12/05/2001 | EP0855912B1 Nitrogen monoxide composition for use as a drug |
| 12/05/2001 | EP0851856B1 Indole derivatives as melatoninergic analogues |
| 12/05/2001 | EP0850204B1 Photocatalytic coating substrate |
| 12/05/2001 | EP0846114B1 3-pyridyloxyalkyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
| 12/05/2001 | EP0845988B1 Novel fused isoquinolines as dopamine receptor ligands |
| 12/05/2001 | EP0845003B1 Novel opioid peptides |
| 12/05/2001 | EP0835244B1 Diheterocyclic acrylonitriles as smooth muscle cell proliferation inhibitors |
| 12/05/2001 | EP0828724B1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors |
| 12/05/2001 | EP0821684B1 Benzimidazole compounds and their use as modulators of the gaba a? receptor complex |
| 12/05/2001 | EP0814815A4 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 12/05/2001 | EP0814800B1 Water-based topical cream containing nitroglycerin; method of preparation and use thereof |
| 12/05/2001 | EP0789687B1 Ep2-receptor agonists as agents for lowering intraocular pressure |
| 12/05/2001 | EP0779886B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 12/05/2001 | EP0754176B1 Novel carbamates and ureas as modifiers of multi-drug resistance |
| 12/05/2001 | EP0749437B1 Pharmaceutical uses of steroid derivatives |
| 12/05/2001 | EP0745075B1 6-substituted mycophenolic and derivatives with immunosuppressive activity |
| 12/05/2001 | EP0745071B1 4-amino 6-substituted mycophenolic acid and derivatives with immunosuppressive activity |
| 12/05/2001 | EP0721337B1 Oral formulations of an antifungal |
| 12/05/2001 | EP0710112B1 Use of vitamin D and derivatives thereof for the manufacture of a medicament for protection against neuron loss |
| 12/05/2001 | EP0697867B1 Compositions in the form of solid solutions |
| 12/05/2001 | EP0692972B1 Method for delivering beneficial compositions to hair follicles |
| 12/05/2001 | EP0669912B1 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists |
| 12/05/2001 | EP0644890B1 Oligonucleotide-polyamide conjugates |
| 12/05/2001 | EP0643701B1 Benzimidazole-derived compounds, method for preparing same, and therapeutical and cosmetic uses thereof |
| 12/05/2001 | EP0636026B1 Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor |
| 12/05/2001 | EP0605493B1 THIADIAZOLO (4,3-a)PYRIDINE DERIVATIVES, METHODS OF PREPARING THEM AND DRUGS CONTAINING THEM |
| 12/05/2001 | EP0590072B1 Use of spin trapping for the treatment of diseases associated with oxidation of lipids and proteins |
| 12/05/2001 | EP0548103B1 Use of pyridylmethylsulphinyl-1h-benzimidazole derivates in the treatment of illnesses caused by helicobacter bacteria |
| 12/05/2001 | EP0445255B2 USE OF HYALURONIC ACID IN COMBINATION WITH ASCORBIC ACID, ANTITUMOUR AGENTS AND/OR NSAIDs FOR TREATING CANCER |
| 12/05/2001 | CN1325453A Vancoresmycin, a process for its production and its use as a pharmaceutical |
| 12/05/2001 | CN1325452A Method for the preparation of quercetin and isoquercetin derivatives |
| 12/05/2001 | CN1325450A Adenovirus-mediated gene therapy |
| 12/05/2001 | CN1325441A Modified exosomes and uses |
| 12/05/2001 | CN1325407A Platelet-derived growth factor D, DNA coding therefor and uses thereof |
| 12/05/2001 | CN1325403A Bile-acid substituted phenyl-alkenoylguanidines, method for the production thereof, use thereof as medicaments or diaymostic agents and medicaments that contain |
| 12/05/2001 | CN1325399A Pyrroloindoles, pyridoindoles and azepinoindoles as 5-HT2c agonists |
| 12/05/2001 | CN1325398A Pyrazolopyrimidinone derivatives for the treatment of impotence |
| 12/05/2001 | CN1325397A 2-piperazino alkylatnino benzoazole derivatives: dopamine receptor subtype sepcific ligands |
| 12/05/2001 | CN1325396A Aryl-{4-fluoro-4-[(2-pyridin-2-YL-ethylamino)-methyl]-piperidin-1-yl}-methanone derivatives as 5-HT1 receptor antagonists |
| 12/05/2001 | CN1325393A Method for producing luteolin and luteolin derivatives |
| 12/05/2001 | CN1325390A 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 12/05/2001 | CN1325389A 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 12/05/2001 | CN1325388A Aza-cyclodepsipeptides and their use as antiparasitics |
| 12/05/2001 | CN1325387A 2,4-disubstituted triazine derivatives |
| 12/05/2001 | CN1325385A Gastrin and cholecystokinin receptor ligands |
| 12/05/2001 | CN1325384A Anthranilic acid amides and the use thereof as medicaments |